# EISMEA's Biotech Investments: 73 Startups in Its Portfolio (2026) > The 73 Biotech startups EISMEA has backed, by stage: $656M raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/eismea-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Stage not reported 56 - [*N* Ncardia](https://millionrounds.com/company/ncardia) - [Alginor ASA](https://millionrounds.com/company/alginor-asa) - [In Ovo](https://millionrounds.com/company/in-ovo) - [Cristal Therapeutics](https://millionrounds.com/company/cristal-therapeutics) - [TargImmune Therapeutics](https://millionrounds.com/company/targimmune-therapeutics) - [CH-Bioforce Oy](https://millionrounds.com/company/ch-bioforce-oy) - [Avectas](https://millionrounds.com/company/avectas) - [AFYX Therapeutics](https://millionrounds.com/company/afyx-therapeutics) - [Genome Biologics](https://millionrounds.com/company/genome-biologics) - [CellPly](https://millionrounds.com/company/cellply) - [Multiplicom](https://millionrounds.com/company/multiplicom) - [LipUm](https://millionrounds.com/company/lipum) - [uFraction8](https://millionrounds.com/company/ufraction8) - [Samplix](https://millionrounds.com/company/samplix) - [Astraveus](https://millionrounds.com/company/astraveus) - [Sensius](https://millionrounds.com/company/sensius) - [Peptomyc](https://millionrounds.com/company/peptomyc) - [Khondrion](https://millionrounds.com/company/khondrion) - [MYSPHERA](https://millionrounds.com/company/mysphera) - [FlowForma](https://millionrounds.com/company/flowforma) - [Life Length](https://millionrounds.com/company/life-length) - [HAWK Biosystems](https://millionrounds.com/company/hawk-biosystems) - [TransCure bioServices](https://millionrounds.com/company/transcure-bioservices) - [Graphenea](https://millionrounds.com/company/graphenea) +32 more ## Series A 9 - [TENSIVE](https://millionrounds.com/company/tensive) - [Depixus](https://millionrounds.com/company/depixus) - [EpiEndo Pharmaceuticals](https://millionrounds.com/company/epiendo-pharmaceuticals) - [Oxford Endovascular](https://millionrounds.com/company/oxford-endovascular) - [BioCopy](https://millionrounds.com/company/biocopy) - [*P* Puridify](https://millionrounds.com/company/puridify) - [Ophiomics](https://millionrounds.com/company/ophiomics) - [Aspivix](https://millionrounds.com/company/aspivix) - [LipoCoat](https://millionrounds.com/company/lipocoat) ## Pre-seed and seed 5 - [Bioaxial](https://millionrounds.com/company/bioaxial) - [HEPHAISTOS-Pharma](https://millionrounds.com/company/hephaistos-pharma) - [Zymvol Biomodeling](https://millionrounds.com/company/zymvol-biomodeling) - [Kamleon](https://millionrounds.com/company/kamleon) - [Regulaxis SAS](https://millionrounds.com/company/regulaxis-sas) ## Series B 3 - [Mimetas](https://millionrounds.com/company/mimetas) - [PreOmics](https://millionrounds.com/company/preomics) - [Hemotune](https://millionrounds.com/company/hemotune) ## Segment by segment ### Stage not reported 56 startups · $408M raised - [*N* **Ncardia**](https://millionrounds.com/company/ncardia) Belgium $72M - [**Alginor ASA**](https://millionrounds.com/company/alginor-asa) Alginor ASA seeks towards a sustainable and resource efficient future based on seaweed treasures from beyond the Arctic Circle. Norway $43M - [**In Ovo**](https://millionrounds.com/company/in-ovo) In Ovo combines animal welfare and efficiency by offering biotechnological solutions to the poultry industry. Netherlands $43M - [**Cristal Therapeutics**](https://millionrounds.com/company/cristal-therapeutics) Cristal Therapeutics is a pharmaceutical company developing a new class of nanomedicine based on its proprietary polymeric technologies. Netherlands $24M - [**TargImmune Therapeutics**](https://millionrounds.com/company/targimmune-therapeutics) TargImmune Therapeutics is focused on drug development using novel targeted onco-immunotherapies. Switzerland $19M - [**CH-Bioforce Oy**](https://millionrounds.com/company/ch-bioforce-oy) CH-Bioforce is the developer of the best biomass fractionation technology in the world. Finland $17M - [**Avectas**](https://millionrounds.com/company/avectas) Avectas is a privately-owned cell therapy manufacturing technology company based in Dublin, Ireland, with additional offices in Ca Ireland $15M - [**AFYX Therapeutics**](https://millionrounds.com/company/afyx-therapeutics) AFYX Therapeutics is a clinical stage biopharmaceutical company Denmark $13M ### Series A 9 startups · $167M raised - [**TENSIVE**](https://millionrounds.com/company/tensive) Tensive is a biomedical startup established in 2012 to develop innovative prostheses aiming to substitute silicone implants. Italy $38M - [**Depixus**](https://millionrounds.com/company/depixus) Depixus is a life-science technology company based in Paris, France, specializing in magnetic force spectroscopy (MFS) to analyze France $35M - [**EpiEndo Pharmaceuticals**](https://millionrounds.com/company/epiendo-pharmaceuticals) EpiEndo Pharmaceuticals is a clinical biopharmaceutical company focused on novel solutions for chronic airway diseases. Iceland $23M - [**Oxford Endovascular**](https://millionrounds.com/company/oxford-endovascular) Oxford Endovascular are developing a novel treatment for treating brain aneurysms. United Kingdom $21M - [**BioCopy**](https://millionrounds.com/company/biocopy) BioCopy developed an innovative, patented technique to copy biomolecules analogous to a photocopier. Germany $20M - [*P* **Puridify**](https://millionrounds.com/company/puridify) PURIDIFY WAS ACQUIRED BY GE HEALTHCARE, NOW CYTIVA IN 2017 Global demand for cheaper biotherapeutics drives the need for bioproces United Kingdom $17M - [**Ophiomics**](https://millionrounds.com/company/ophiomics) Ophiomics is a precision medicine biotechnology and medtech company based in Lisbon, Portugal. Portugal $6.5M - [**Aspivix**](https://millionrounds.com/company/aspivix) Aspivix is a Swiss-based medical device company founded in 2015, focused on advancing women’s healthcare through innovative gyneco Switzerland $5.1M ### Pre-seed and seed 5 startups · $16M raised - [**Bioaxial**](https://millionrounds.com/company/bioaxial) Bioaxial develops new technologies for fluorescence microscopy to improve extended imaging of live cells. France $6.9M - [**HEPHAISTOS-Pharma**](https://millionrounds.com/company/hephaistos-pharma) Hephaistos Pharma is a biotech company developing oncology treatments. France $4.9M - [**Zymvol Biomodeling**](https://millionrounds.com/company/zymvol-biomodeling) Zymvol Biomodeling is a biotechnology company based in Barcelona, founded in 2017. Spain $3.1M - [**Kamleon**](https://millionrounds.com/company/kamleon) Based in Barcelona, Kamleon is a science-based early-stage company developing user-centered technologies that aims to motivate peo Spain $1.1M - [**Regulaxis SAS**](https://millionrounds.com/company/regulaxis-sas) Regulaxis SAS is a French biotechnology company founded in 2013 and located in Romainville, near Paris. France $426K ### Series B 3 startups · $65M raised - [**Mimetas**](https://millionrounds.com/company/mimetas) MIMETAS develops organ-on-a-chip tissue- and disease models for better, more reliable, and tailored medicines. Netherlands $30M - [**PreOmics**](https://millionrounds.com/company/preomics) PreOmics GmbH is a biotechnology company focused on mass spectrometry-based proteomics. Germany $19M - [**Hemotune**](https://millionrounds.com/company/hemotune) Hemotune is a medical device company that develops a therapeutic blood purification platform for treatment of health ailments. Switzerland $16M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names EISMEA as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **EISMEA's Healthtech portfolio** 30 startups · $97M](https://millionrounds.com/portfolio-maps/eismea-healthtech-portfolio)[Sector portfolio **EISMEA's AI portfolio** 28 startups · $184M](https://millionrounds.com/portfolio-maps/eismea-ai-portfolio)[Sector portfolio **EISMEA's Cleantech portfolio** 23 startups · $128M](https://millionrounds.com/portfolio-maps/eismea-cleantech-portfolio)[Sector portfolio **EISMEA's Energy portfolio** 15 startups · $89M](https://millionrounds.com/portfolio-maps/eismea-energy-portfolio)[Sector portfolio **EISMEA's Hardware & Electronics portfolio** 14 startups · $24M](https://millionrounds.com/portfolio-maps/eismea-hardware-electronics-portfolio)[Sector portfolio **EISMEA's Big Data & Analytics portfolio** 13 startups · $41M](https://millionrounds.com/portfolio-maps/eismea-big-data-analytics-portfolio) ## Raising from investors like EISMEA? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)